dc.contributor.author |
Harvey, M |
|
dc.contributor.author |
Sleigh, J |
|
dc.contributor.author |
Voss, L |
|
dc.contributor.author |
Jose, J |
|
dc.contributor.author |
Gamage, S |
|
dc.contributor.author |
Pruijn, F |
|
dc.contributor.author |
Liyanage, S |
|
dc.contributor.author |
Denny, W |
|
dc.date.accessioned |
2021-01-12T01:45:02Z |
|
dc.date.available |
2021-01-12T01:45:02Z |
|
dc.date.issued |
2016-8 |
|
dc.identifier.issn |
0039-6206 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/54173 |
|
dc.description.abstract |
A major adverse effect of ketamine is its psychomimetic properties, which can cause prolonged psychic disturbances lasting 20 to 120 minutes after anesthesia. Ketamine analogs with rapid clearance might limit this pyschomimetic period to only a few minutes, while retaining the hypnotic characteristics of ketamine. |
|
dc.language |
en |
|
dc.publisher |
Ovid Technologies (Wolters Kluwer Health) |
|
dc.relation.ispartofseries |
Survey of Anesthesiology |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.title |
Development of Rapidly Metabolized and Ultra-Short–Acting Ketamine Analogs |
|
dc.type |
Journal Article |
|
dc.identifier.doi |
10.1097/SA.0000000000000243 |
|
pubs.issue |
4 |
|
pubs.begin-page |
170 |
|
pubs.volume |
60 |
|
dc.date.updated |
2020-12-02T08:51:53Z |
|
dc.rights.holder |
Copyright: The author |
en |
pubs.end-page |
170 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Editorial Comment |
|
pubs.elements-id |
612023 |
|